Evaluation of computerized decision support for oral anticoagulation management based in primary care

British Journal of General Practice

Volumn 46, Issue 410, 1996, Pages 533-535

  Fitzmaurice, D A ^a   Hobbs, F D R ^a   Murray, E T ^a   Bradley, C P ^a   Holder, R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Computerized decision support (DSS); Oral anticoagulation; Primary care; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ARTICLE; BLEEDING; CITY; CLINICAL ARTICLE; COMPUTER SYSTEM; CONTROLLED STUDY; DECISION MAKING; DRUG DOSE; DRUG SAFETY; DRUG USE; GENERAL PRACTICE; HOSPITAL; HUMAN; PATIENT MONITORING; PATIENT SATISFACTION; PRIMARY MEDICAL CARE; REGRESSION ANALYSIS; TREATMENT OUTCOME; UNITED KINGDOM;

ADMINISTRATION, ORAL; ANTICOAGULANTS; COSTS AND COST ANALYSIS; DECISION MAKING, COMPUTER-ASSISTED; FAMILY PRACTICE; HEALTH CARE COSTS; HUMANS; PATIENT SATISFACTION; WARFARIN;

EID: 0029750217     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lowe GDO. Anti-thrombotic treatment and atrial fibrillation. BMJ 1992; 305: 1445-1446.
2. Gustafson C, Asplund K, Britton M, Norrving B, Olsson B, Marke LA. Cost effectiveness of primary prevention in atrial fibrillation: Swedish national perspective. BMJ 1992; 305: 1457-1460.
3. Sandercock P et al. Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis. (Oxfordshire Community Stroke Project). BMJ 1992; 305: 1460-1465.
4. Sweeney KG, Pereira-Gray D, Steele R, Evans P. Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice. Br J Gen Pract 1995; 45: 153-158.
5. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects. Am J Cardiol 1994; 74: 236-241.
6. Poller L. Optimal therapeutic range for oral anticoagulation. In: Poller L (ed). Recent advances in blood coagulation. Edinburgh: Churchill Livingstone, 1991; 5: 245-264.
7. Van den Besselar AMHP. Recommended method for reporting therapeutic control of oral anticoagulant therapy. Thromb Haemost 1990; 63: 316-317.
8. Landefeld CS, Beyth RJ, Anticoagulant related bleeding: clinical epidemiology, prediction, and prevention. Am J Med 1993; 95: 315-328.
9. Mcinnes GT, Helenglass G. The performance of clinics for outpatient control of anti-coagulation. J R Coll Physicians Lond 1987; 21: 42-45.
10. Doble N, Baron JH, Anticoagulation control with warfarin by junior hospital doctors. J R Soc Med 1987; 80: 627.
11. Pell JP, McIver B, Stuart P, Malone DNS, Alcock J. Comparison of anti-coagulant control among patients attending general practice and a hospital anti-coagulant clinic. Br J Gen Pract 1993; 43: 152-154.
12. Ryan P, Gilbert M, Rose PE. Computer control of anti-coagulant dose for therapeutic management. BMJ 1989; 299: 1207-1209.
13. British Committee for Standardisation in Haematology. Guidelines on oral anti-coagulation, 2nd Edition. J Clin Pathol 1990; 43: 177-183.
14. Taylor F, Ramsay M, Vole J, Cohen H. Anticoagulation in patients with atrial fibrillation. GPs not prepared for monitoring anticoagulation. BMJ 1993; 307: 1493.
15. Shakespeare J. Anticoagulation in patients with atrial fibrillation. GPs struggle to meet demand. BMJ 1994; 308: 415.
16. Poller L, Wright D, Rowlands M. Prospective comparative study of computer programs used for management of warfarin. J Clin Pathol 1993; 46: 299-303.
17. Ware JE, Snyder MK, Wright WR, Davies AR. Defining and measuring patient satisfaction with medical care. Evaluation and Program Planning 1983; 6: 247-263.